Send to a Friend Font Size: Increase Decrease

HALO and MRUS Related Headlines

Nov 17, 2025 07:00AM Merus and Halozyme partner on subcutaneous petosemtamab formulation
Nov 17, 2025 07:00AM Merus and Halozyme partner on subcutaneous petosemtamab formulation
Nov 17, 2025 07:00AM Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab

HALO and MRUS Related Press Releases

Nov 17, 2025 07:00AM Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab

HALO and MRUS Related SEC Filings